Chemical Structure : WMJ-J-09
CAS No.: 2416914-29-7
货号: PC-24736Not For Human Use, Lab Use Only.
WMJ-J-09 is a potent, hydroxamate based HDAC inhibitor, exhibits potent inhibitory activity against class I HDACs, including HDAC1 (IC50=7.5 nM), HDAC2 (IC50=21.3 nM), HDAC3 (IC50=18.4 nM), and HDAC8 (IC50=90.9 nM), also strongly inhibitsHDAC6 (class IIb) with IC50 of 3.9 nM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥980 | In stock | |
| 10 mg | ¥1480 | In stock | |
| 25 mg | ¥2580 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
WMJ-J-09 is a potent, hydroxamate based HDAC inhibitor, exhibits potent inhibitory activity against class I HDACs, including HDAC1 (IC50=7.5 nM), HDAC2 (IC50=21.3 nM), HDAC3 (IC50=18.4 nM), and HDAC8 (IC50=90.9 nM), also strongly inhibitsHDAC6 (class IIb) with IC50 of 3.9 nM.
WMJ-J-09 arrests the cell cycle and induced apoptosis in HCT116 cells.
WMJ-J-09 shows moderate inhibition toward HDAC4 (class IIa) with an IC50 of 8715.7 nM.
WMJ-J-09 significantly reduces the polymerized tubulin fraction through HDAC inhibition.
WMJ-J-09 caused HCT116 cell death may involve p21 elevation and survivin suppression.
WMJ-J-09 triggers LKB1-p38MAPK-p53 signaling pathway to increases p21 expression and survivin reduction, culminating in HCT116 cell death.
WMJ-J-09 induced survivin degradation.
WMJ-J-09 (20 mg/kg/day) inhibits growth of the HCT116 tumor xenograft, does not impact mouse body weight.
| 分子量 | 445.53 | |
| 分子式 | C22H27N3O5S | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
N1-hydroxy-N8-(1-(phenylsulfonyl)indolin-6-yl)octanediamide |
|
1. Yen CS, et al. Front Pharmacol. 2018 Mar 1;9:167.
2. Huang YH, et al. Sci Rep. 2025 Jun 4;15(1):19590.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright